8 unknown, 1 completed. 6 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 5, Completed 1 |
| Not applicable | 2 | Unknown 2 |
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment Laboratory Samples - Covid19, Cancer | Unknown | Auxilio Mutuo Cancer Center | 250 | 2021-02-16 | 2021-03-03 | |
| Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm MethylPREDNISolone 80 Mg/mL Injectable Suspension - Covid-19 | Phase 2 | Unknown | Auxilio Mutuo Cancer Center | 20 | 2020-04-14 | 2020-04-21 |
| Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas Tea Made of Graviola Leaves - Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction | Not applicable | Unknown | Auxilio Mutuo Cancer Center | 54 | 2018-11-07 | 2021-02-26 |
| "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab - Infiltrating Duct and Lobular Carcinoma In Situ, Invasive Lobular Breast Carcinoma | Phase 2 | Unknown | Auxilio Mutuo Cancer Center | 60 | 2011-03-01 | 2012-07-16 |
| Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma rituximab, gemcitabine hydrochloride, lenalidomide - Lymphoma | Phase 2 | Unknown | Auxilio Mutuo Cancer Center | 70 | 2011-02-01 | 2014-01-10 |
| Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia valproic acid, western blotting, laboratory biomarker analysis - Leukemia, Lymphoma | Phase 2 | Unknown | Auxilio Mutuo Cancer Center | 52 | 2009-08-01 | 2014-01-10 |
| Study of Neoadjuvant Chemotherapy of Breast Cancer Neoadjuvant chemotherapy, Chemotherapy - Breast Cancer | Phase 2 | Unknown | Auxilio Mutuo Cancer Center | 54 | 2008-07-01 | 2012-07-13 |
| Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy PET scan after course 1 and surgery after 8 courses - Invasive Ductal Carcinoma, Lobular Breast Carcinoma | Not applicable | Unknown | Auxilio Mutuo Cancer Center | 80 | 2007-07-01 | 2012-07-13 |
| Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas Rituximab, Gemcitabine, Oxaliplatin - Refractory Aggressive Non-Hodgkin's Lymphoma, Relapsing Aggressive Non-Hodgkin's Lymphoma | Phase 2 | Completed | Auxilio Mutuo Cancer Center | 43 | 2003-10-01 | 2012-07-13 |
Burkitt Lymphoma (2) · COVID-19 (2) · Carcinoma, Lobular (2) · Inflammatory Breast Neoplasms (2) · Lymphoma (2) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell, Peripheral (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Breast Carcinoma In Situ (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · HIV Infections (1) · Hodgkin Disease (1)
Gemcitabine (2) · Neoadjuvant Therapy (2) · Oxaliplatin (2) · Rituximab (2) · Bevacizumab (1) · Blotting, Western (1) · Capecitabine (1) · Cyclophosphamide (1) · Docetaxel (1) · Drug Therapy (1) · Epirubicin (1) · Lenalidomide (1) · Methylprednisolone (1) · Trastuzumab (1) · Valproic Acid (1)
Puerto Rico (8)